Qingdao Baheal Medical, INC. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Qingdao Baheal Medical, INC.

Why is Qingdao Baheal Medical, INC. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.18% and Operating profit at 11.92% over the last 5 years

With a fall in Net Sales of -8.07%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 2 consecutive quarters
INTEREST(HY) At CNY 42.13 MM has Grown at 40.24%
INVENTORY TURNOVER RATIO(HY) Lowest at 7.07%
NET SALES(Q) At CNY 1,831.58 MM has Fallen at -9%

With ROE of 28.92%, it has a expensive valuation with a 1.51 Price to Book Value

Over the past year, while the stock has generated a return of -16.79%, its profits have fallen by -16.6%

Below par performance in long term as well as near term

Along with generating -16.79% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Qingdao Baheal Medical, INC. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Qingdao Baheal Medical, INC.

-12.67%

-0.45

44.03%

China Shanghai Composite

14.61%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.18%

EBIT Growth (5y)

11.92%

EBIT to Interest (avg)

13.38

Debt to EBITDA (avg)

0.43

Net Debt to Equity (avg)

0.39

Sales to Capital Employed (avg)

1.66

Tax Ratio

21.06%

Dividend Payout Ratio

57.91%

Pledged Shares

Institutional Holding

ROCE (avg)

25.95%

ROE (avg)

21.96%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.51

EV to EBIT

5.48

EV to EBITDA

4.77

EV to Capital Employed

1.32

EV to Sales

0.55

PEG Ratio

Dividend Yield

ROCE (Latest)

24.13%

ROE (Latest)

28.92%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 985.23 MM

RAW MATERIAL COST(Y)

Fallen by -23.31% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 3.6%

-18What is not working for the Company

INTEREST(HY)

At CNY 42.13 MM has Grown at 40.24%

INVENTORY TURNOVER RATIO(HY)

Lowest at 7.07%

NET SALES(Q)

At CNY 1,831.58 MM has Fallen at -9%

NET PROFIT(Q)

At CNY 103.78 MM has Fallen at -39.69%

Here's what is working for Qingdao Baheal Medical, INC.

Operating Cash Flow

Highest at CNY 985.23 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio

Highest at 3.6%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -23.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Qingdao Baheal Medical, INC.

Interest

At CNY 42.13 MM has Grown at 40.24%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 7.07% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

At CNY 1,831.58 MM has Fallen at -9%

over average net sales of the previous four periods of CNY 2,012.63 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Profit

At CNY 103.78 MM has Fallen at -39.69%

over average net sales of the previous four periods of CNY 172.09 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)